fingolimod richter
gedeon richter plc - fingolimodas - kietosios kapsulės - 0,5 mg - fingolimod
dimethyl fumarate mylan
mylan ireland limited - dimetilfumaratas - išsėtinė sklerozė, grįžtamoji-pervedimo - imunosupresantai - dimethyl fumarate mylan is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.
dimethyl fumarate polpharma
zaklady farmafarmaceutyczne polpharma s.aceutyczne polpharma s.a. - dimetilfumaratas - išsėtinė sklerozė, grįžtamoji-pervedimo - imunosupresantai - dimethyl fumarate polpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.
uplizna
horizon therapeutics ireland dac - inebilizumab - neuromyelitis optica - imunosupresantai - uplizna is indicated as monotherapy for the treatment of adult patients with neuromyelitis optica spectrum disorders (nmosd) who are anti-aquaporin 4 immunoglobulin g (aqp4-igg) seropositive (see section 5.
fingolimod stada
stada arzneimittel ag - fingolimodas - kietosios kapsulės - 0,5 mg - fingolimod
inzolfi
sandoz d.d. - fingolimodas - kietosios kapsulės - 0,25 mg - fingolimod
bonaxon
egis pharmaceuticals plc - fingolimodas - kietosios kapsulės - 0,5 mg - fingolimod
dimethyl fumarate teva
teva gmbh - dimetilfumaratas - multiple sclerosis, relapsing-remitting; multiple sclerosis - imunosupresantai - dimethyl fumarate teva is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).
dimethyl fumarate accord
accord healthcare s.l.u. - dimetilfumaratas - multiple sclerosis, relapsing-remitting; multiple sclerosis - imunosupresantai - dimethyl fumarate accord is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).
dimethyl fumarate stada
stada arzneimittel ag - dimetilfumaratas - skrandyje neirios kietosios kapsulės - 120 mg - dimethyl fumarate